Clinical studies recruiting near Beverly Hills

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide W
Phase 3 · Cedars-Sinai Cancer Beverly Hills (drug treatment and dispen · Pfizer · NCT07028853 Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for MS
Phase 1 · The Foundation for Orthopaedics and Regenerative Medicine · NCT05003388 Safety and Feasibility of Umbilical Cord Wharton's Jelly Allograft Injections for Lumbar Pain
Phase 1 · R3 Anti Aging Beverly Hills · R3 Stem Cell · NCT06361485 To Evaluate the Safety and Efficacy of MANP in Subjects With Difficult to Control/ Resistant Hypertension
Phase 2 · Amicis Research Center - Beverly Hills · E-Star BioTech, LLC · NCT06343298 Study of Intravenously (IV) Infused Etentamig in Combination With an Oral Cereblon E3 Ligase Modulatory Drug (CELMoD) Ag
Phase 1 · Beverly Hills Cancer Center /ID# 266921 · AbbVie · NCT06896916 A Study to Assess the Effectiveness and Safety of IPN10200 Over Time in Adults With Moderate to Severe Wrinkle-like Line
Phase 3 · Ipsen · NCT07435428 Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Phase 2/Phase 3 · Tower Cancer Research Foundation · NRG Oncology · NCT05174169 A Study to Assess Adverse Events and Change in Disease Activity in Participants 12 Years of Age or Older With Locally Ad
Phase 2 · Beverly Hills Cancer Center /ID# 275465 · AbbVie · NCT07196644 E-Mindfulness Approaches for Living After Breast Cancer
Phase 3 · NRG Oncology · NCT06748222 FOLFIRI and Bevacizumab With or Without Pelareorep for Second-Line Treatment of Metastatic RAS-Mutated, Microsatellite-S
Phase 2 · Clinical Research Advisors (Beverly Hills) · Oncolytics Biotech · NCT07446322 Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for OA
Phase 1 · The Foundation for Orthopaedics and Regenerative Medicine · NCT05147675 Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectab
Phase 2 · Tower Cancer Research Foundation · NRG Oncology · NCT05327686 Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
Phase 1 · Beverly Hills Cancer Center · SystImmune Inc. · NCT05983432 A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Meta
Phase 2 · Beverly Hills Cancer Center · Puma Biotechnology, Inc. · NCT06369285 Phase II Trial of Ivonescimab in Combination With Carboplatin + Docetaxel in Patients With Early-Stage Triple Negative B
Phase 2 · Cedars-Sinai Medical Center · NCT07017673 Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide,
Phase 3 · Tower Cancer Research Foundation · National Cancer Institute (NCI) · NCT06058377 A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
Phase 3 · Beverly Hills Cancer Center Clinical Research Advisors LLC · Janssen Research & Development, LLC · NCT07518186 Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Remo
Phase 2/Phase 3 · National Cancer Institute (NCI) · NCT05987241 Safety of Cultured Autologous Adult Adipose Derived Mesenchymal Stem Cell Versus Cultured Allogeneic Adult Umbilical-cor
Phase 1 · The Foundation for Orthopaedics and Regenerative Medicine · NCT05018793 Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had
Phase 2/Phase 3 · Tower Cancer Research Foundation · SWOG Cancer Research Network · NCT06616584 Safety Study for a Gamma Delta T Cell Product Used With Low Dose Radiotherapy in Patients With Locally Advanced or Metas
Phase 1 · Beverly Hills Cancer Center · Kiromic BioPharma Inc. · NCT06069570 A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Parti
Phase 3 · Beverly Hills Cancer Center ( Site 0070) · Merck Sharp & Dohme LLC · NCT06312137 Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
Phase 3 · Beverly Hills Cancer Center · Novartis Pharmaceuticals · NCT05827081 Study of Osimertinib With Carotuximab in Advanced, EGFR-mutated Non-Small Cell Lung Cancer
Phase 1 · Cedars-Sinai Cancer at Beverly Hills (THO) · Karen Reckamp, MD, MS · NCT05401110 MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Ha
Phase 3 · Beverly Hills Cancer Center · Pfizer · NCT06152575 Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PI
Phase 3 · Beverly Hills Cancer Center · Relay Therapeutics, Inc. · NCT06982521 Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung
Phase 3 · National Cancer Institute (NCI) · NCT04267848 Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Phase 2/Phase 3 · Tower Cancer Research Foundation · SWOG Cancer Research Network · NCT03851445 Fisetin to Improve Physical Function in Stage I-III Breast Cancer Survivors
Phase 2 · UCLA Health Beverly Hills Primary & Specialty Care · Jonsson Comprehensive Cancer Center · NCT05595499 A Study Evaluating the Prophylactic Use of Tocilizumab to Prevent Cytokine Release Syndrome With Ramantamig Administrati
Phase 2 · Beverly Hills Cancer Center (BHCC) · Janssen Research & Development, LLC · NCT07589634

Look up another city

Look up another condition